This review focuses on targeted therapies related to these pathways of interest for the treatment of advanced urothelial carcinoma, describing the evidence to support further investigation of these approaches.
Brandon P. Verdoorn, MD
Advertisement
Articles by Brandon P. Verdoorn, MD
Advertisement
Latest Updated Articles
- Targeted Therapy in Advanced Urothelial Carcinoma
Published: March 16th 2013 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Lifileucel Confers Durable Responses in Pretreated Advanced NSCLC Type
2
How Can Oncology Staffing Shortages Be Remedied?
3
Atezolizumab Combo Elicits No Significant Benefit in Ovarian Cancer
4
Glofitamab/Polatuzumab Vedotin Exhibits Response Durability in R/R LBCL
5
